Alliancebernstein L.P. trimmed its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 55.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 120,561 shares of the company’s stock after selling 149,131 shares during the quarter. Alliancebernstein L.P. owned 0.13% of Acadia Healthcare worth $4,780,000 at the end of the most recent quarter.
Other institutional investors have also recently modified their holdings of the company. Magnetar Financial LLC grew its position in Acadia Healthcare by 385.4% during the 4th quarter. Magnetar Financial LLC now owns 928,772 shares of the company’s stock valued at $36,826,000 after purchasing an additional 737,427 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after buying an additional 454,044 shares during the last quarter. Beach Point Capital Management LP bought a new stake in shares of Acadia Healthcare during the fourth quarter valued at approximately $14,097,000. Vaughan Nelson Investment Management L.P. raised its holdings in Acadia Healthcare by 38.4% in the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 1,064,455 shares of the company’s stock worth $42,206,000 after acquiring an additional 295,515 shares during the last quarter. Finally, Stephens Investment Management Group LLC lifted its position in Acadia Healthcare by 24.9% in the 4th quarter. Stephens Investment Management Group LLC now owns 1,475,166 shares of the company’s stock valued at $58,490,000 after acquiring an additional 294,210 shares in the last quarter.
Acadia Healthcare Price Performance
Shares of Acadia Healthcare stock opened at $26.15 on Monday. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a 52 week low of $25.41 and a 52 week high of $82.41. The stock’s 50-day simple moving average is $33.22 and its 200-day simple moving average is $40.94. The company has a market capitalization of $2.43 billion, a price-to-earnings ratio of 8.57, a PEG ratio of 1.46 and a beta of 1.13.
Wall Street Analysts Forecast Growth
Check Out Our Latest Analysis on ACHC
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- 3 Tickers Leading a Meme Stock Revival
- Is McDonald’s Stock Serving a Value Meal to Investors?
- EV Stocks and How to Profit from Them
- Walgreens Comeback? Private Equity Circling for a Buyout
- How to Invest in the Best Canadian StocksÂ
- Coca-Cola Stock Looks Refreshing After the Relief Rally
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.